Brand name
Trikafta, the original
We didn’t find a savings card or cash price from Trikafta’s maker. Ask the pharmacy for Trikafta’s cash price. With insurance, ask what your plan charges.
Generic name: elexacaftor, tezacaftor, and ivacaftor
Used for: Cystic fibrosis (with certain CFTR gene changes)
Ask for the cash price
Trikafta
We didn’t find one.
Trikafta, the original
We didn’t find a savings card or cash price from Trikafta’s maker. Ask the pharmacy for Trikafta’s cash price. With insurance, ask what your plan charges.
There isn’t one.
We didn’t find one.
TRIKAFTA is a combination of ivacaftor, a CFTR potentiator, tezacaftor, and elexacaftor indicated for the treatment of cystic fibrosis (CF) in adult and pediatric patients aged 2 years and older who have a clinical diagnosis of CF and who have at least one variant in the CFTR gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein.
If the patient's genotype is unknown, an FDA-cleared CF genetic test should be used to confirm the presence of at least one variant in the CFTR gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein.
Source: the FDA label for Trikafta (Vertex Pharmaceuticals Incorporated), June 22, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/trikafta/